|
Template proteins with similar binding site:
Click to view | Rank | CscoreLB | PDB Hit | TM-score | RMSDa | IDENa | Cov. | BS-score | Lig. Name | Download Complex | Predicted binding site residues |
| 1 | 0.61 | 1jqiA | 0.930 | 0.33 | 0.917 | 0.932 | 1.84 | CAA | complex1.pdb.gz | 118,122,152,160,161,163,207,261,265,266,268,269,272,342,391,392,393,397,401 |
| 2 | 0.56 | 2vigA | 0.916 | 0.50 | 0.997 | 0.920 | 1.92 | FAD | complex2.pdb.gz | 152,154,155,160,161,185,187,230,238,387,390,391,392,394,396,397,400 |
| 3 | 0.52 | 2vigB | 0.899 | 0.25 | 0.997 | 0.900 | 0.88 | COS | complex3.pdb.gz | 152,265,266,268,269,272,392,393 |
| 4 | 0.25 | 1t9g1 | 0.904 | 1.15 | 0.373 | 0.922 | 1.38 | III | complex4.pdb.gz | 157,158,162,185,226,229,230,231,232,297,361,364,365,368,370,372,373,374,375,379,382,383,386,387,389,390,396 |
| 5 | 0.08 | 1t9g2 | 0.906 | 1.16 | 0.372 | 0.925 | 1.23 | III | complex5.pdb.gz | 33,34,96,287,288,291,295,305,311,312,315,316,319,322,323,326,329,330,333,339,343,347,351,396,399,400,402,403 |
| | Click on the radio buttons to visualize predicted binding site and residues. |
| (a) | CscoreLB is the confidence score of predicted binding site. CscoreLB values range in between [0-1]; where a higher score indicates a more reliable ligand-binding site prediction. |
| (b) | BS-score is a measure of local similarity (sequence & structure) between template binding site and predicted binding site in the query structure. Based on large scale benchmarking analysis, we have observed that a BS-score >1 reflects a significant local match between the predicted and template binding site.
| | (c) | TM-score is a measure of global structural similarity between query and template protein. |
| (d) | RMSDa the RMSD between residues that are structurally aligned by TM-align. |
| (e) | IDENa is the percentage sequence identity in the structurally aligned region. |
| (f) | Cov. represents the coverage of global structural alignment and is equal to the number of structurally aligned residues divided by length of the query protein. |
|